The 1 analysts offering 12-month price forecasts for Intellipharmaceutics International Inc have a median target of 25.00, with a high estimate of 25.00 and a low estimate of 25.00. The median estimate represents a +18,418.52% increase from the last price of 0.14.
The current consensus among 1 polled investment analysts is to Hold stock in Intellipharmaceutics International Inc. This rating has held steady since November, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Mar 02
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.